Stock listing

Frankfurt:PHS Photocure ASA Aktie

German listing (Frankfurt) of Photocure ASA · home listing Oslo:PHO

Follow Photocure ASA into a list and get an email when it puts out news.

Share price · FWB:PHS

€3.89 EUR +0.08 (+2.2%)

Close on Nov 20, 2026

Past year -15.1% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€3.89 – €3.89 EURNov 20, 2026
Market cap
€104.6M EURAt the close on Nov 20, 2026 · price × 26.92M shares outstanding
52-week range
€3.89 – €6.71 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€0 EURMedian day 0 shares · 57 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Photocure ASA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Oslo:PHO · Home41.25 NOK-0.45 (-1.1%)46,69141.3541.5540.8541.70Close on Nov 20, 2026
LSE:0IMT40.85 NOK-1.20 (-2.9%)6641.1041.1040.8542.05Close on Nov 17, 2026
Frankfurt:PHS€3.885 EUR+0.085 (+2.2%)—€3.885€3.885€3.885€3.80Close on Nov 20, 2026
Stuttgart:PHS€3.75 EUR-0.13 (-3.4%)—€3.88€3.89€3.695€3.88Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:PHS · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€4.148-0.004-0.1%€4.148€4.148€4.1480
€4.152-0.053-1.3%€4.152€4.152€4.1520
€4.205-0.095-2.2%€4.205€4.205€4.2050
€4.30-0.079-1.8%€4.30€4.30€4.300
€4.379-0.044-1.0%€4.379€4.379€4.3790
€4.423-0.078-1.7%€4.423€4.423€4.4230
€4.501-0.213-4.5%€4.501€4.501€4.5010
€4.714+0.086+1.9%€4.714€4.714€4.7140
€4.628-0.049-1.0%€4.628€4.628€4.6280
€4.677+0.105+2.3%€4.677€4.677€4.6770
€4.572-0.116-2.5%€4.572€4.572€4.5720
€4.688+0.07+1.5%€4.688€4.688€4.6880
€4.618+0.019+0.4%€4.618€4.618€4.6180
€4.599+0.02+0.4%€4.599€4.599€4.5990
€4.579+0.066+1.5%€4.579€4.579€4.5790
€4.513+0.0010.0%€4.513€4.513€4.5130
€4.512+0.045+1.0%€4.512€4.512€4.5120
€4.467-0.024-0.5%€4.467€4.467€4.4670
€4.491-0.033-0.7%€4.491€4.491€4.4910
€4.524+0.11+2.5%€4.524€4.524€4.5240
€4.414-0.077-1.7%€4.414€4.414€4.4140
€4.491+0.093+2.1%€4.491€4.491€4.4910
€4.398+0.02+0.5%€4.398€4.398€4.3980
€4.378-0.074-1.7%€4.378€4.378€4.3780
€4.452+0.067+1.5%€4.452€4.452€4.4520
€4.385-0.073-1.6%€4.385€4.385€4.3850
€4.458-0.061-1.3%€4.458€4.458€4.4580
€4.519+0.097+2.2%€4.519€4.519€4.5190
€4.422-0.057-1.3%€4.422€4.422€4.4220
€4.479-0.143-3.1%€4.479€4.479€4.4790
€4.622-0.041-0.9%€4.622€4.622€4.6220
€4.663-0.022-0.5%€4.663€4.663€4.6630
€4.685-0.08-1.7%€4.685€4.685€4.6850
€4.765+0.102+2.2%€4.765€4.765€4.7650
€4.663-0.021-0.4%€4.663€4.663€4.6630
€4.684+0.022+0.5%€4.684€4.684€4.6840
€4.662+0.057+1.2%€4.662€4.662€4.6620
€4.605-0.02-0.4%€4.605€4.605€4.6050
€4.625-0.065-1.4%€4.625€4.625€4.6250
€4.69-0.10-2.1%€4.69€4.69€4.690
€4.79-0.054-1.1%€4.79€4.79€4.790
€4.844-0.023-0.5%€4.844€4.844€4.8440
€4.867+0.017+0.4%€4.867€4.867€4.8670
€4.85+0.018+0.4%€4.85€4.85€4.850
€4.832-0.026-0.5%€4.832€4.832€4.8320
€4.858-0.015-0.3%€4.858€4.858€4.8580
€4.873-0.063-1.3%€4.873€4.873€4.8730
€4.936+0.038+0.8%€4.936€4.936€4.9360
€4.898-0.116-2.3%€4.898€4.898€4.8980
€5.014+0.004+0.1%€5.014€5.014€5.0140
€5.01+0.109+2.2%€5.01€5.01€5.010
€4.901-0.017-0.3%€4.901€4.901€4.9010
€4.918+0.059+1.2%€4.918€4.918€4.9180
€4.859+0.025+0.5%€4.859€4.859€4.8590
€4.834-0.028-0.6%€4.834€4.834€4.8340
€4.862-0.009-0.2%€4.862€4.862€4.8620
€4.871-0.154-3.1%€4.871€4.871€4.8710
Ticker
Frankfurt:PHS
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Photocure ASA news

Photocure ASA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
21 in the last 12 months · 29 in all · newest Aug 17, 2026 · oldest 2025
Calls
12 calls with a replay · 12 with a transcript · latest Oct 28, 2026
Decks
119 decks · latest Oct 28, 2026

Where Photocure ASA is listed

ListingExchangeCountryCurrency
Oslo:PHO · Home listingOsloNorwayNOK
OTC:PHCUFOTCUnited StatesUSD
LSE:0IMTLSEUnited KingdomNOK
LS Exchange:931150LS ExchangeGermanyEUR
gettex:PHSgettexGermanyEUR
Lang & Schwarz:931150Lang & SchwarzGermanyEUR
Stockholm:PHOOStockholmSwedenNOK
Aquis:PHOOAquisUnited KingdomNOK
Aquis:PHOOAquisUnited KingdomNOK
Frankfurt:PHS · This pageFrankfurtGermanyEUR
Dusseldorf:PHSDusseldorfGermanyEUR
Stuttgart:PHSStuttgartGermanyEUR
Turquoise:PHOOTurquoiseUnited KingdomNOK

Valuation

P/E 22.9× against a median of 32.3×: 3rd lowest of 7 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
947.9M NOK
P/E
22.9×
EV/sales
1.4×
EV/EBITDA
6.1×
Price/book
1.9×
Gross margin
93.9%
Operating margin
14.9%
Net margin
7.1%
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Photocure ASA · OSL:PHOUS$113.9MUS$97.23M22.9×1.4×6.1×1.9×7.1%0.0×n/a
Bioventix PLC · LSE:BVXPUS$133.3MUS$126.3M13.4×7.4×9.7×9.2×57.8%0.0×n/a
Curiosis, Inc. · KRX:494120US$131.1MUS$117.6Mn/a18.7×n/a7.1×−93.3%0.0×n/a
Bioneer Corporation · KRX:064550US$127.6MUS$107.1Mn/a0.4×10.0×0.8×−1.9%0.3×n/a
Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FFUS$123.5MUS$174.6M11.1×0.6×4.6×0.8×4.0%0.6×n/a
Burning Rock Biotech Ltd. · NASDAQ:BNRUS$116.7MUS$60.54Mn/a0.8×n/a1.6×−13.6%0.1×1.51
BIODYNE Co., Ltd. · KRX:314930US$115.0MUS$104.0M182×19.9×70.7×3.5×12.1%0.0×n/a
ArcticZymes Technologies ASA · OSL:AZTUS$108.4MUS$80.84M66.1×6.2×24.6×3.0×12.7%0.0×n/a
NanoenTek, Inc. · KRX:039860US$107.8MUS$71.26M24.8×2.2×17.4×1.5×13.3%0.0×n/a
BICO Group AB Class B · OMXSTO:BICOUS$102.7MUS$90.50Mn/a0.6×2.1×0.8×−28.3%0.3×n/a
Devyser Diagnostics AB · OMXSTO:DVYSRUS$99.24MUS$94.86M39.9×3.8×17.5×2.6×10.0%0.1×n/a
Median of the othersUS$115.8MUS$99.43M32.3×3.0×13.7×2.1×7.0%0.1×1.51

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
75.00 NOK · Analysts' mean
EPS, year to Dec 2026
0.68 · 1 analyst
Revenue, year to Dec 2026
696M · 2 analysts

Events

Next results
Feb 17, 2027 (expected)

Calls

CallWhenStatus
Photocure (Oslo:PHO) Q3 2026 Earnings CallWed, Oct 28, 2026 · 9:00 AM ETReplay
Photocure (Oslo:PHO) Q2 2026 Earnings CallWed, Jul 29, 2026 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q1 2026 Earnings CallThu, May 07, 2026 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q4 2025 Earnings CallWed, Feb 18, 2026 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q3 2025 Earnings CallWed, Oct 29, 2025 · 9:00 AM ETReplay
Photocure (Oslo:PHO) Q2 2025 Earnings CallWed, Jul 30, 2025 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q1 2025 Earnings CallThu, May 08, 2025 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q4 2024 Earnings CallWed, Feb 19, 2025 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q3 2024 Earnings CallWed, Nov 13, 2024 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q2 2024 Earnings CallWed, Aug 07, 2024 · 8:00 AM ETReplay
All 12 calls
CallWhenStatus
Photocure (Oslo:PHO) Q1 2024 Earnings CallSat, May 25, 2024 · 8:00 AM ETReplay
Photocure (Oslo:PHO) Q1 2023 Earnings CallWed, May 10, 2023 · 9:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 28, 2026 · After close−1.7%
Q2 2026Jul 29, 2026 · Before open−4.8%
Q1 2026May 7, 2026 · Before open+0.5%
Q4 2025Feb 18, 2026 · Before open+1.0%
Q3 2025Oct 29, 2025 · Before open+1.7%
Q2 2025Jul 30, 2025 · Before open+11.0%
Q1 2025May 8, 2025 · Before open−4.6%
Q4 2024Feb 19, 2025 · Before open−7.9%
Q3 2024Nov 13, 2024 · Before open−2.8%
Q2 2024Aug 7, 2024 · Before open+0.8%
All 20 quarters
QuarterResultsShare move
Q1 2024May 15, 2024 · Before open−4.1%
Q4 2023Feb 21, 2024 · Before open−6.8%
Q3 2023Nov 8, 2023 · Before open+0.7%
Q2 2023Aug 9, 2023 · Before open−2.5%
Q1 2023May 10, 2023 · Before open−5.2%
Q4 2022Feb 23, 2023 · Before open−16.7%
Q3 2022Nov 2, 2022 · Before open+7.3%
Q2 2022Aug 10, 2022 · Before open−2.5%
Q1 2022May 11, 2022 · Before open−3.2%
Q4 2021Feb 23, 2022 · Before open+6.5%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings25 slidesOct 28, 2026
Q2 2026 Earnings PresentationEarnings24 slidesJul 29, 2026
Merger or Acquisition (June 2026)Merger or acquisition17 slidesJun 4, 2026
Q1 2026 Earnings PresentationEarnings27 slidesMay 7, 2026
Q4 2025 Earnings PresentationEarnings27 slidesFeb 18, 2026
Q3 2025 Earnings PresentationEarnings21 slidesOct 29, 2025
Q2 2025 Earnings PresentationEarnings20 slidesJul 30, 2025
Investor Presentation (July 2025)Investor deck16 slidesJuly 2025
Q1 2025 Earnings PresentationEarnings20 slidesMay 8, 2025
Q4 2024 Earnings PresentationEarnings22 slidesFeb 19, 2025
Show 50 decks
DeckKindSlidesDate
Q3 2024 Earnings PresentationEarnings20 slidesNov 13, 2024
Q2 2024 Earnings PresentationEarnings24 slidesAug 7, 2024
Fact Sheet (August 2024)Fact sheet1 slideAugust 2024
Q1 2024 Earnings PresentationEarnings18 slidesMay 25, 2024
Q4 2023 Earnings PresentationEarnings17 slidesFeb 21, 2024
Q3 2023 Earnings PresentationEarnings17 slidesNov 8, 2023
Q2 2023 Earnings PresentationEarnings17 slidesAug 9, 2023
Q1 2023 Earnings PresentationEarnings19 slidesMay 10, 2023
FY2022 Earnings PresentationEarnings21 slidesFeb 23, 2023
Q3 2022 Earnings PresentationEarnings18 slidesNov 2, 2022
Q2 2022 Earnings PresentationEarnings20 slidesAug 10, 2022
Q1 2022 Earnings PresentationEarnings23 slidesMay 11, 2022
Q4 2021 Earnings PresentationEarnings25 slidesFeb 23, 2022
Q3 2021 Earnings PresentationEarnings24 slidesNov 17, 2021
Q2 2021 Earnings PresentationEarnings25 slidesAug 11, 2021
Q1 2021 Earnings PresentationEarnings23 slidesMay 19, 2021
Q4 2020 Earnings PresentationEarnings29 slidesMar 3, 2021
DNB Virtual Healthcare Conference 2020Conference18 slidesDec 15, 2020
Q3 2020 Earnings PresentationEarnings28 slidesNov 10, 2020
Q2 2020 Earnings PresentationEarnings33 slidesAug 18, 2020
Shareholder Meeting (June 2020)Shareholder meeting13 slidesJun 10, 2020
ABG Sundal Collier Virtual Oncology Seminar 2020Conference26 slidesJun 10, 2020
Q1 2020 Earnings PresentationEarnings37 slidesMay 7, 2020
Corporate Update (April 2020)Corporate update40 slidesApr 27, 2020
Q4 2019 Earnings PresentationEarnings31 slidesFeb 27, 2020
Q3 2019 Earnings PresentationEarnings32 slidesNov 7, 2019
Norne Securities Vekst & Verdi Aksjeseminar in Vilnius 2019Conference26 slidesSep 20, 2019
H.C. Wainwright 21st Annual Global Investment Conference 2019Conference23 slidesSeptember 2019
Q2 2019 Earnings PresentationEarnings27 slidesAug 7, 2019
European Biotech Investor Day 2019 in New YorkConference17 slidesAugust 2019
Q1 2019 Earnings PresentationEarnings28 slidesMay 14, 2019
Q4 2018 Earnings PresentationEarnings22 slidesFeb 27, 2019
Q3 2018 Earnings PresentationEarnings24 slidesNov 8, 2018
Q2 2018 Earnings PresentationEarnings23 slidesAug 8, 2018
Q1 2018 Earnings PresentationEarnings20 slidesMay 23, 2018
J.P. Morgan – BioNJ Eighth Annual Bio-Partnering Conference 2018Conference13 slidesMay 3, 2018
Q4 2017 Earnings PresentationEarnings21 slidesFeb 27, 2018
J.P. Morgan Healthcare Conference 2018Conference24 slidesJan 8, 2018
Carnegie Nordic Healthcare Day 2017Conference22 slidesDec 5, 2017
Q3 2017 Earnings PresentationEarnings22 slidesNov 8, 2017

This page holds 50 of 119 decks. Open Decks

Open Decks

Financials

Annual, in NOK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue532.6M525.4M500.7M393.1M360.5M256.5M281.6M181.5M150.9M143.6M
Cost of revenue42.0M30.7M26.1M22.7M24.1M18.5M22.5M17.1M12.0M9.34M
Gross profit490.6M494.7M474.5M370.4M336.5M238.0M259.0M164.4M138.9M134.3M
Research and development402.0K3.63M2.07M3.34M4.32M13.8M13.6M19.1M32.6M23.0M
Selling, general and administrative363.7M354.9M334.9M303.4M259.9M187.8M148.7M121.3M96.4M79.9M
Operating income-743.0K20.4M27.8M-49.0M-5.83M-13.3M42.7M-37.9M-45.2M-15.9M
Depreciation and amortization29.5M28.8M27.7M24.4M24.1M19.3M16.2M13.2M12.1M7.85M
EBITDA28.7M49.2M55.5M-24.6M18.3M5.95M59.0M-24.7M-33.1M-8.01M
Interest expense33.6M36.9M41.2M30.6M34.8M7.03M0000
Income before tax-16.7M8.39M9.74M-71.1M-31.7M-33.2M45.9M-36.7M-41.6M12.8M
Income tax-15.2M11.7M8.76M723.0K-759.0K-10.8M14.1M-6.00K-6.88M-22.5M
Net income-1.52M-3.34M979.0K-71.9M-30.9M-22.4M31.8M-36.7M-34.7M35.3M
Earnings per share, basic-0.06-0.190.04-2.66-115.00-0.901.46-1.70-1.611.64
Earnings per share, diluted-0.06-0.190.04-2.66-115.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents238.9M293.9M259.5M268.1M322.9K329.5M121.2M102.5M125.3M165.3M
Short-term investments79.1M101.0M141.7M
Receivables74.9M66.9M59.7M47.2M48.0M43.8M45.1M32.3M26.7M29.0M
Inventory44.4M39.5M37.2M26.5M27.5M29.7M16.4M18.6M19.6M17.5M
Current assets385.3M424.0M372.4M358.2M413.2M412.2M186.9M153.4M175.6M211.8M
Property, plant and equipment42.2M36.2M33.5M32.5M33.6M5.79M9.05M2.14M1.27M1.66M
Goodwill144.0M144.0M144.0M144.0M144.0M144.0M
Total assets706.6M739.1M712.0M719.0M789.6M776.0M257.4M231.2M263.1M285.9M
Accounts payable30.0M19.4M19.7M21.3M23.6M23.3M5.12M10.2M15.1M9.91M
Current liabilities110.9M103.9M83.1M104.1M113.6M79.8M38.7M52.5M40.3M30.1M
Long-term debt100.1M117.1M0012.5M37.5M
Total debt15.4M15.8M14.0M27.4M36.6M53.9M6.95M
Total liabilities222.3M237.4M229.1M256.3M287.0M267.9M48.8M54.9M45.0M33.9M
Shareholders' equity484.2M501.7M482.8M462.7M502.6M508.1M208.6M176.3M218.1M251.9M
Shares outstanding26.6M27.1M27.1M27.1M27.1M24.8M21.8M21.6M21.6M21.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations31.7M76.8M48.3M-2.02M23.9M15.6M20.7M-24.1M-23.6M19.2M
Capital spending-21.7M-11.4M-12.3M-3.61M-3.70M-1.60M-1.24M-2.19M-18.6M-22.1M
Free cash flow9.98M65.3M36.0M-5.63M20.2M14.0M19.4M-26.3M-42.2M-2.91M
Cash from investing-9.46M1.42M-594.0K-1.46M-1.90M-166.2M610.0K-1.06M-16.3M13.9M
Cash from financing-77.2M-43.8M-56.3M-51.3M-34.0M360.2M-2.78M2.65M2.65M2.13M
Share buybacks-29.7M07.58M13.9M314.7M614.0K-377.0K03.40M
Change in cash-55.0M34.4M-8.57M-54.8M-12.0M209.6M18.5M-22.5M-39.9M35.2M

Open Financials

Cap table

Built by 6ix from Photocure ASA’s releases

Common shares
26,916,610
Fully diluted
26,916,610

Fully diluted

LineShares
Common shares26,916,610

Share count over time

CountShares
Nov 22, 202626,916,610

Open Cap table

Shareholders

HolderSharesValueChangeAs of
The Continental Small Company Series106KUS$593K−2,596Jul 31, 2026
Dimensional International Small Cap ETF46,837US$262KNo changeJul 31, 2026
International Core Equity 2 Portfolio37,584US$211K+4,128Jul 31, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF17,673US$106K+183Jun 30, 2026
Dimensional International Core Equity 2 ETF14,831US$82,879+3,414Jul 31, 2026
Voya Multi-Manager International Small Cap Fund11,294US$63,158No changeJul 31, 2026
International Sustainability Core 1 Portfolio6,697US$37,583No changeJul 31, 2026
Dimensional International Core Equity Market ETF6,438US$35,977No changeJul 31, 2026
Parametric International Equity Fund6,070US$34,064No changeJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF4,482US$25,047No changeJul 31, 2026
All 18 holders
HolderSharesValueChangeAs of
Siit World Equity Ex-Us Fund3,637US$24,417NewMay 31, 2026
Dimensional VA International Small Portfolio3,580US$20,091No changeJul 31, 2026
International Small Company Trust2,625US$15,739No changeJun 30, 2026
Brighthouse/Dimensional International Small Company Portfolio2,065US$12,381No changeJun 30, 2026
World ex U.S. Core Equity Portfolio1,570US$8,811No changeJul 31, 2026
State Street(R) SPDR(R) Portfolio Europe ETF1,030US$6,172−24Jun 30, 2026
SIT International Equity Fund227US$1,361NewJun 30, 2026
Dimensional International Sustainability Core 1 ETF8US$45No changeJul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Erik DahlUntil Jun 30, 2026 · Past

Open People

Log in to ask 6ix AI your own questions about Photocure ASA.